These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34332663)

  • 1. The role of atrial fibrillation catheter ablation in patients with heart failure.
    Bernard ML; Benn F; Williams CM; Hiltbold AE; Rogers PA; Polin GM; Khatib S; Al-Khatib SM; Morin DP
    Prog Cardiovasc Dis; 2021; 66():80-85. PubMed ID: 34332663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
    AlTurki A; Proietti R; Dawas A; Alturki H; Huynh T; Essebag V
    BMC Cardiovasc Disord; 2019 Jan; 19(1):18. PubMed ID: 30646857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.
    Sohns C; Zintl K; Zhao Y; Dagher L; Andresen D; Siebels J; Wegscheider K; Sehner S; Boersma L; Merkely B; Pokushalov E; Sanders P; Schunkert H; Bänsch D; Mahnkopf C; Brachmann J; Marrouche NF
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008461. PubMed ID: 32903044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early catheter ablation of atrial fibrillation in patients with heart failure.
    Tóth P; Arnóth B; Komlósi F; Szegedi N; Salló Z; Perge P; Osztheimer I; Merkely B; Gellér L; Nagy KV;
    J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1471-1479. PubMed ID: 38803006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction.
    Smer A; Salih M; Darrat YH; Saadi A; Guddeti R; Mahfood Haddad T; Kabach A; Ayan M; Saurav A; Abuissa H; Elayi CS
    Clin Cardiol; 2018 Nov; 41(11):1430-1438. PubMed ID: 30178507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes.
    Younis A; Tabaja C; Santangeli P; Nakagawa H; Sipko J; Madden R; Bouscher P; Taigen T; Higuchi K; Hayashi K; El Hajjar AH; Chamseddine F; Callahan T; Martin DO; Nakhla S; Kanj M; Sroubek J; Lee JZ; Saliba WI; Wazni OM; Hussein AA
    Circ Arrhythm Electrophysiol; 2024 Sep; 17(9):e012926. PubMed ID: 39193716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation for persistent atrial fibrillation in patients with heart failure: is it underutilized?
    Pappone C; Santinelli V
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e99-e102. PubMed ID: 29538154
    [No Abstract]   [Full Text] [Related]  

  • 8. Ablation of atrial fibrillation in patients with heart failure deserves more than a IIb guidelines recommendation.
    Chelu MG; Marrouche NF
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1412-1415. PubMed ID: 31120159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design.
    Parkash R; Wells G; Rouleau J; Talajic M; Essebag V; Skanes A; Wilton SB; Verma A; Healey JS; Tang AS
    Am Heart J; 2021 Apr; 234():90-100. PubMed ID: 33472052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).
    Hunter RJ; Berriman TJ; Diab I; Kamdar R; Richmond L; Baker V; Goromonzi F; Sawhney V; Duncan E; Page SP; Ullah W; Unsworth B; Mayet J; Dhinoja M; Earley MJ; Sporton S; Schilling RJ
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):31-8. PubMed ID: 24382410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centers.
    Providência R; de Asmundis C; Chun J; Chierchia G; Defaye P; Anselme F; Creta A; Lambiase PD; Schmidt B; Chen S; Hunter RJ; Combes S; Honarbakhsh S; Combes N; Sousa MJ; Jebberi Z; Albenque JP; Boveda S
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1270-1277. PubMed ID: 31190350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR
    Mathew JS; Marzec LN; Kennedy KF; Jones PG; Varosy PD; Masoudi FA; Maddox TM; Allen LA
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction.
    Bunch TJ; May HT; Bair TL; Jacobs V; Crandall BG; Cutler M; Weiss JP; Mallender C; Osborn JS; Anderson JL; Day JD
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):363-370. PubMed ID: 25534572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Therapeutic Assessment of Atrial Fibrillation in Heart Failure With Reduced Ejection Fraction-A Network Meta-Analysis.
    Malik AH; Aronow WS
    Am J Ther; 2020; 27(3):e286-e296. PubMed ID: 30615598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction.
    Long S; Xi Y; Gao L; Chen Q; Cheng J; Yang Y; Xia Y; Yin X
    Clin Cardiol; 2020 Mar; 43(3):305-314. PubMed ID: 31808172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
    Briceño DF; Markman TM; Lupercio F; Romero J; Liang JJ; Villablanca PA; Birati EY; Garcia FC; Di Biase L; Natale A; Marchlinski FE; Santangeli P
    J Interv Card Electrophysiol; 2018 Oct; 53(1):19-29. PubMed ID: 30066291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.